Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment

被引:89
作者
Cheung, Connie [1 ]
Gonzalez, Frank J. [1 ]
机构
[1] Natl Canc Inst, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1124/jpet.108.141242
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450s (P450s) are important enzymes involved in the metabolism of xenobiotics, particularly clinically used drugs, and are also responsible for metabolic activation of chemical carcinogens and toxins. Many xenobiotics can activate nuclear receptors that in turn induce the expression of genes encoding xenobiotic metabolizing enzymes and drug transporters. Marked species differences in the expression and regulation of cytochromes P450 and xenobiotic nuclear receptors exist. Thus, obtaining reliable rodent models to accurately reflect human drug and carcinogen metabolism is severely limited. Humanized transgenic mice were developed in an effort to create more reliable in vivo systems to study and predict human responses to xenobiotics. Human P450s or human xenobiotic-activated nuclear receptors were introduced directly or replaced the corresponding mouse gene, thus creating "humanized" transgenic mice. Mice expressing human CYP1A1/CYP1A2, CYP2E1, CYP2D6, CYP3A4, CY3A7, pregnane X receptor, and peroxisome proliferator-activated receptor alpha were generated and characterized. These humanized mouse models offer a broad utility in the evaluation and prediction of toxicological risk that may aid in the development of safer drugs.
引用
收藏
页码:288 / 299
页数:12
相关论文
共 70 条
  • [1] Rifampin drastically reduces plasma concentrations and effects of oral midazolam
    Backman, JT
    Olkkola, KT
    Neuvonen, PJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (01) : 7 - 13
  • [2] Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man
    Bogaards, JJP
    Bertrand, M
    Jackson, P
    Oudshoorn, MJ
    Weaver, RJ
    van Bladeren, PJ
    Walther, B
    [J]. XENOBIOTICA, 2000, 30 (12) : 1131 - 1152
  • [3] Rifampicin, a keystone inducer of drug metabolism: From Herbert Remmer's pioneering ideas to modern concepts
    Bolt, HM
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 (3-4) : 497 - 509
  • [4] Identification of a subtype selective human PPARα agonist through parallel-array synthesis
    Brown, PJ
    Stuart, LW
    Hurley, KP
    Lewis, MC
    Winegar, DA
    Wilson, JG
    Wilkinson, WO
    Ittoop, OR
    Willson, TM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) : 1225 - 1227
  • [5] THE CURRENT STATUS OF ATTEMPTS TO PREDICT SPECIES-DIFFERENCES IN DRUG-METABOLISM
    CALDWELL, J
    [J]. DRUG METABOLISM REVIEWS, 1981, 12 (02) : 221 - 237
  • [6] Oxidative stress, toxicology, and pharmacology of CYP2E1
    Caro, AA
    Cederbaum, AI
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 27 - 42
  • [7] Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice
    Cheung, C
    Yu, AM
    Chen, CS
    Krausz, KW
    Byrd, LG
    Feigenbaum, L
    Edwards, RJ
    Waxman, DJ
    Gonzalez, FJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) : 1328 - 1334
  • [8] Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2
    Cheung, C
    Ma, XC
    Krausz, KW
    Kimura, S
    Feigenbaum, L
    Dalton, TP
    Nebert, DW
    Idle, JR
    Gonzalez, FJ
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (09) : 1471 - 1478
  • [9] The CYP2E1-humanized transgenic mouse:: Role of CYP2E1 in acetaminophen hepatotoxicity
    Cheung, C
    Yu, AM
    Ward, JM
    Krausz, KW
    Akiyama, TE
    Feigenbaum, L
    Gonzalez, FJ
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) : 449 - 457
  • [10] Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor α
    Cheung, C
    Akiyama, TE
    Ward, JM
    Nicol, CJ
    Feigenbaum, L
    Vinson, C
    Gonzalez, FJ
    [J]. CANCER RESEARCH, 2004, 64 (11) : 3849 - 3854